Ground Swell Capital’s Puma Biotechnology PBYI Stock Holding History

Ground Swell Capital’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$24K	Buy	+100	New	+$20.5K	0.05%	456

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Ground Swell Capital's PBYI Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Puma Biotechnology (PBYI) in Q3 2014: 100 shares worth $24K. The stake represents 0.05% of the portfolio and ranks #456 among its holdings.

184 funds tracked by Wall St. Rank hold PBYI as of Q3 2014.

Ground Swell Capital held 100 shares of Puma Biotechnology worth $24K as of Q3 2014.
Puma Biotechnology was a new Ground Swell Capital position in Q3 2014.
Puma Biotechnology made up 0.05% of Ground Swell Capital's portfolio in Q3 2014, its #456 holding.
184 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.